GSK3923868 inhalation powder
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3923868 inhalation powder, covering 2024-05-06 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma [Phase 1]